Board Meeting on Feb 06, 2017
Balaji Amines Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 06, 2017, inter alia:1. To Consider and approve the un audited financial results for the 3rd quarter ended December, 31, 2016.2. To consider and approve the scheme of Amalgamation of M/s Balaji Greentech Products Limited and M/s Bhagyanagar Chemicals Limited with M/s Balaji Amines Limited.... Shareholding for the Period Ended December 31, 2016
Balaji Amines Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Balaji Amines Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Intimation of Schedule of Analyst / Institutional Investor Meeting
Balaji Amines Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meeting". Updates on Outcome of Board Meeting
With reference to the earlier letter dated October 24, 2016 regarding Outcome of Board Meeting, Balaji Amines Ltd has now informed BSE that: "We bring to your kind notice item No. 4 of our outcome of the Board Meeting dated October 24, 2016 to read as follows;The Board has revised the proposed new Morpholine Plant at Unit-Ill with an installed capacity of 7000 MT/PA as against the earlier disclosed 10000 MT/PA in the Board outcome... Updates on Outcome of Board Meeting
Balaji Amines Ltd has informed BSE that the Board of Directors, at its meeting held on October 24, 2016, have approved in principle, the proposal of Amalgamation of its Subsidiaries, M/s. Balaji Greentech Products Limited and M/s. Bhagyanagar Chemicals Limited with M/s. Balaji Amines Limited and in this regard constituted committee of directors called as Merger Committee with the terms of reference as below... Outcome of Board Meeting
Balaji Amines Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 24, 2016, inter - alia, transacted the following matters:1. The Board has revised the Morpholine plant installed capacity from 10000 MT/PA to 7000 MT/PA due to economies of scale and detailed engineering.2. The board authorized SRI.G.HEMANTH REDDY, Director as Authorised person under Investor Education and Protection Fund Authority... Standalone Financial Results, Limited Review Report for September 30, 2016
Balaji Amines Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016 Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Balaji Amines Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended September 30, 2016
Balaji Amines Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here